Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06060626
Collaborator
Military University Hospital, Prague (Other)
60
1
2
14
4.3

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate the effect of opioids administered during sedation on patients' respiratory activity (ventilation) and comfort of the operator and patient during the endoscopic procedure. A common side effect of sedation is the effect on patients' ventilation, resulting from a combination of attenuation of respiratory centre activity and loss of patent airways. Shallow sedation will reduce these risks, but in addition to patient discomfort, it also increases the difficulty or impossibility of the endoscopist to perform the procedure. Choosing the appropriate method of sedation thus fundamentally affects the course of the procedure from the point of view of both the patient and the endoscopist. The aim is to prove that sedation with propofol alone compared to sedation with propofol and fentanyl premedication leads to the need for higher cumulative doses of administered propofol, higher risk of respiratory depression and lower patient and operator comfort. In addition, the non-invasive respiratory volume monitor (ExSpiron 2Xi) will be used for standard patient monitoring during the procedure, which assesses the lung tidal volume and respiratory rate by measuring the electrical impedance of the chest. This measurement captures inadequate ventilation before saturation drops, allowing even slight differences between selected drugs to be compared.

Condition or Disease Intervention/Treatment Phase
  • Drug: Sedation using only Propofol.
  • Drug: Sedation using combination of Propofol and Fentanyl.
N/A

Detailed Description

The aim of the study is to evaluate the effect of opioids administered during sedation on patients' respiratory activity (ventilation) and comfort of the operator and patient during the endoscopic procedure. A common side effect of sedation is the effect on patients' ventilation, resulting from a combination of attenuation of respiratory centre activity and loss of patent airways. Shallow sedation will reduce these risks, but in addition to patient discomfort, it also increases the difficulty or impossibility of the endoscopist to perform the procedure. Choosing the appropriate method of sedation thus fundamentally affects the course of the procedure from the point of view of both the patient and the endoscopist. The aim is to prove that sedation with propofol alone compared to sedation with propofol and fentanyl premedication leads to the need for higher cumulative doses of administered propofol, higher risk of respiratory depression and lower patient and operator comfort. Standard monitoring during endoscopic procedures using sedation includes continual recording of ECG and respiratory rate (using the same electrodes), measurement of arterial blood oxygen saturation using a pulse oximeter and blood pressure measurement. Extended monitoring of spontaneous ventilation during sedation includes analysis of the concentration of exhaled carbon dioxide or analysis of the arterial blood gases.However, these methods have limitations and often critically reduced respiratory activity is diagnosed too late. Impedance monitoring of ventilation is now being introduced into clinical practice. In addition, the non-invasive respiratory volume monitor (ExSpiron 2Xi) will be used for standard patient monitoring during the procedure, which assesses the lung tidal volume and respiratory rate by measuring the electrical impedance of the chest. This measurement captures inadequate ventilation before saturation drops, allowing even slight differences between selected drugs to be compared.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study will be performed on a sample of patients undergoing an endoscopic procedure requiring sedation. Patients will be divided into two groups, one group will be sedated with propofol only, the other will be premedicated with the opioid analgesic fentanyl before the procedure.The study will be performed on a sample of patients undergoing an endoscopic procedure requiring sedation. Patients will be divided into two groups, one group will be sedated with propofol only, the other will be premedicated with the opioid analgesic fentanyl before the procedure.
Masking:
Single (Care Provider)
Masking Description:
The endoscopist performing the procedure will not be informed which group the patient belongs to.
Primary Purpose:
Supportive Care
Official Title:
Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Propofol

Patients in whom only propofol will be administered during sedation. Intermittent boluses of propofol titrated to moderate level of sedation.

Drug: Sedation using only Propofol.
Patients in whom only propofol will be administered during sedation.
Other Names:
  • Propofol
  • Active Comparator: Fentanyl

    Patients in whom combination of propofol and fentanyl will be administered during sedation. Fentanyl 1 ug/kg bolus 3 minutes before induction + Propofol intermittent boluses titrated to moderate level of sedation.

    Drug: Sedation using combination of Propofol and Fentanyl.
    Patients in whom combination of propofol and fentanyl will be administered during sedation.
    Other Names:
  • Fentanyl
  • Outcome Measures

    Primary Outcome Measures

    1. Incidence of significant decrease in ventilation during propofol sedation. [during the endoscopic procedure]

      Incidence of significant decrease in ventilation during sedation with propofol alone during endoscopic surgery.

    2. Incidence of significant decrease in ventilation during propofol and fentanyl sedation. [during the endoscopic procedure]

      Incidence of significant decrease in ventilation during sedation with propofol and fentanyl during endoscopic surgery.

    Secondary Outcome Measures

    1. Subjective assessment of the comfort of the procedure by the endoscopist. [immediately after the procedure]

      Subjective assessment of the comfort of the procedure by the endoscopist using a questionnaire.

    2. Subjective assessment of the comfort of the procedure by the patient. [immediately after the procedure]

      Subjective assessment of the comfort of the procedure by the patient using a questionnaire.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Scheduled therapeutic or diagnostic colonoscopy with sedation

    • Supine or lateral decubitus position

    • Age 18-65

    • American Society of Anesthesiologists (ASA) physical status classification system 1-2

    • Informed consent signed

    Exclusion Criteria:
    • Planned frequent use of electrocoagulation

    • Contact allergy for adhesive pads, excessive thoracic hair or other problem with pads

    • contraindication of using Propofol or Fentanyl

    • Incapability to understand the informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Military University Hospital Prague Praha Czechia 16209

    Sponsors and Collaborators

    • Charles University, Czech Republic
    • Military University Hospital, Prague

    Investigators

    • Study Chair: Ilona Trtíková, Mgr., Ph.D., CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
    • Principal Investigator: David Novotný, M.D., CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
    • Principal Investigator: Tomáš Tyll, M.D., Ph.D., CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
    • Principal Investigator: Michal Soták, M.D., Ph.D., CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Charles University, Czech Republic
    ClinicalTrials.gov Identifier:
    NCT06060626
    Other Study ID Numbers:
    • ExSpironUVN
    First Posted:
    Sep 29, 2023
    Last Update Posted:
    Oct 2, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Charles University, Czech Republic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 2, 2023